Pivot Bio, founded in 2011 and headquartered in the United States, stands out as a pivotal player in the Agriculture, Biotechnology, and AgriTech industries. It has branded itself as one of the world's leading innovative agtech companies with a focus on delivering patented crop nutrition technologies to farmers.
The most recent funding milestone is a significant $430.00M Series D investment, secured on 01 July 2021. This distinguished funding round saw participation from a robust cohort of investors including DCVC, Prelude Ventures, Breakthrough Energy Ventures, Generation Investment Management, Bunge Ventures, Pavilion Capital, Tekfen Ventures, Temasek, Rockefeller Asset Management, G2 Venture Partners (G2VP), Continental Grain, and Roger Underwood.
As it continues to innovate in agtech, Pivot Bio's ability to attract a diverse and strategic group of investors highlights its potential for growth and lasting impact in sustainable agriculture, positioning it as a valuable prospect for new investors seeking to make a significant contribution to the future of farming.